External advisory bodies for Health Canada
In fulfilling its mandate to help people in Canada maintain and improve their health, Health Canada seeks information and advice from other people, groups, agencies and governments. This includes seeking advice from experts using external advisory bodies. These bodies are composed of people who are outside of the federal government, chosen for their knowledge, expertise and experience.
The Health Canada Policy on External Advisory Bodies provides direction to those managing external advisory bodies and how to use their advice. The policy also provides stakeholders and members of the public with accessible information on what to expect when Health Canada seeks advice from an external advisory body.
Learn more:
Active external advisory bodies
Scientific advisory bodies
- Science Advisory Committee on Health Products Containing Cannabis
- Science Advisory Committee on Pest Control Products
- Scientific Advisory Board on Vaping Products
- Scientific Advisory Committee on Digital Health Technology
- Scientific Advisory Committee Medical Devices Used in the Cardiovascular System
- Scientific Advisory Committee on Health Products for Women
- Scientific Advisory Committee on Oncology Therapies
- Scientific Advisory Committee on Pharmaceutical Sciences and Clinical Pharmacology
- Scientific Advisory Committee on Respiratory and Allergy Therapies
Other advisory bodies
- Chemicals Management Plan Science Committee
- Expert Advisory Group on Safer Supply
- Implementation Advisory Group (IAG) for the National Strategy for Drugs for Rare Diseases
- Ministerial Advisory Council on Mental Health
- National Pharmacare Committee of Experts
- Pest Management Advisory Council
- Youth Leadership Team (Substance Use)
Inactive or disbanded external advisory bodies
Scientific advisory bodies
Other advisory bodies
- Advisory Council on the Implementation of National Pharmacare
- Appropriate Use Advisory Committee
- Canadian Pain Task Force
- COVID-19 Testing and Screening Expert Advisory Panel
- Expert Advisory Group on Marketing of Opioids
- Expert panel: Cannabis Act legislative review
- Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada
- Expert Panel on MAID and Mental Illness
- Expert Task Force on Substance Use
- Industry Advisory Roundtable on COVID-19 Testing, Screening, Tracing and Data Management
- Review of the Federal Approach to Pandemic Science Advice and Research Coordination
- Task Force on Cannabis Legalization and Regulation
Page details
- Date modified: